Stock news timeline · DRREDDY
DR. REDDY S LABORATORIES
News timeline · Last 30 days
23 Aug 2026 – 21 Sep 2026 · Times in IST
- Timeline updates
- 13
- Bullish
- 4
- Neutral
- 9
- Bearish
- 0
- Active days
- 8
News timeline
Showing 13 of 13 updates · Newest first
No matching updates
Change the keyword or sentiment above, then click Apply.
Friday, 18 Sep 20264 updates
Dr. Reddy's Partners on Dengue Vaccine Qdenga, Launch by H1 2027
Dr. Reddy's partners with Takeda for exclusive distribution of Qdenga, India's first CDSCO-approved dengue vaccine, in private markets. Qdenga targets all four dengue serotypes; expected availability in H1 2027; collaboration enhances India's dengue prevention efforts. Source: BSE
Dr Reddy's Labs:Co. Agrees To Licensing Deal With Gilead For Once-Yearly Lenacapavir To Prevent HIV.
Dr Reddy's Gets License for Gilead's Lenacapavir, No SEBI Disclosure Needed
Dr Reddy’s confirms voluntary license for Gilead’s lenacapavir, as reported on Sep 17, 2026. Company states no material events requiring disclosure under SEBI Regulation 30. Source: BSE
Thursday, 17 Sep 20262 updates
Dr. Reddy's, Gilead Tie-Up for HIV Drug Lenacapavir
Dr. Reddy's signed royalty-free license with Gilead for lenacapavir HIV prevention. The agreement focuses on annual lenacapavir as an HIV prevention option. Source: Livesquawk
Dr Reddy's: Enters Royalty-Free License Agreement With Gilead For Annual Lenacapavir HIV Prevention.
Saturday, 12 Sep 20262 updates
Dr. Reddy’s Labs: USFDA Finishes Inspection At Dr. Reddy’s Labs Facility In Morelos, Mexico Receives Two Observations In Form FDA 2953
Dr Reddy's Mexico Unit Gets 2 USFDA Observations
Dr Reddy’s Mexico API facility receives two USFDA observations after records assessment. USFDA completed evaluation at Industrias Químicas Falcon de México, as per regulatory filing. Source: The Hindu BusinessLine
Thursday, 10 Sep 20261 update
Dr. Reddy's Allots 375 Shares via ESOPs
Dr. Reddy's allotted 375 equity shares under its ESOPs on Sept 10, 2026. Post-allotment, total issued share capital stands at Rs. 83.46 crore. Source: BSE
Wednesday, 02 Sep 20261 update
Drugmakers May Soon Need To Clearly Label Medicines As Synthetic Or Biological Under New Rules - Mint ( Biocon, Dr. Reddy, Zydus ) - Newspaper
Thursday, 27 Aug 20261 update
Dr. Reddy's Sees ₹76 Cr Block Deal on BSE at ₹1,174/Share
Dr. Reddy's traded ~647,500 shares via BSE block trade at Rs 1,174. Total transaction value reached ~Rs 76.02 crore in this trade. Source: Livesquawk
Wednesday, 26 Aug 20261 update
Dr Reddy's Allots 4,110 Shares Under ESOP, Total Capital at ₹83.46 Cr
Dr Reddy's allotted 4,110 equity shares under its ESOP scheme on August 26, 2026. Shares rank pari passu with existing shares; total issued share capital now Rs. 83.46 crore. Source: BSE